Olaris Company
Olaris is on a mission to revolutionize how diseases are diagnosed and treated through the combination of metabolomics and machine learning
Founded Date:
2013-06-01
Employee Number:
1-10
Funding Status:
Early Stage Venture
Technology:
Biopharma, Biotechnology, Health Care
Last Funding Type:
Series B
Investors Number:
3.0
Last Funding Date:
2021-09-23
Industry:
Early Drug Development
Headquarters:
Framingham, Massachusetts, United States
Estimated Revenue:
$1M to $10M